Author: Carol White
“California’s business owners have been hit hard by COVID-19,” said Commissioner Lara. “Workers’ compensation premiums should reflect that many employees are performing less risky duties, and my Order will provide some financial relief for employers when they need it most.”
The nonprofit health care giant was accused of using its market dominance in Northern California to illegally drive up prices.
Small businesses still reeling from the coronavirus pandemic and the related economic lockdown could receive a second loan through the Paycheck Protection Program under new legislation introduced by a group of Democratic lawmakers.
California is seeing a growing number of COVID-19-related hospitalizations and intensive care unit cases, Gov. Gavin Newsom said Monday, making it all the more necessary that people follow his mandatory mask order in public.
The U.S. Small Business Administration and Treasury Department announced Friday that they would release a data set showing which businesses received many taxpayer-funded Paycheck Protection Program loans, walking back an earlier stance that all of the business names would remain hidden because the Trump administration considered them proprietary.
A federal appeals court ruled against the Trump administration on Wednesday, finding that it does not have the legal authority to mandate that drug manufacturers display the prices of their medicines in television advertisements.
After seven days as an inpatient for complications related to heart problems, Glenn Shanoski was initially hesitant when doctors suggested in early April that he could cut his hospital stay short and recover at home — with high-tech 24-hour monitoring and daily visits from medical teams.
Large sections of the healthcare sector all but shut down during the spring as the coronavirus led to nationwide shelter-in-place orders. However, as states and municipalities slowly reopen, so are the doors for hospitals, ambulatory surgical centers, clinics and other integral components of healthcare delivery.
Two new bipartisan bills aim to prevent price gouging for taxpayer-funded treatments and vaccines for coronavirus disease 2019 (COVID-19).
The economic impact of job losses relating to COVID-19 will create a dramatic shift in how individuals access health insurance.